Literature DB >> 3338870

Estimates of the worldwide frequency of sixteen major cancers in 1980.

D M Parkin1, E Läärä, C S Muir.   

Abstract

The numbers of new cancer cases in 16 common sites occurring in 1980 have been estimated for 24 areas of the world for which the United Nations produces population estimates. For the world as a whole, the total number of new cases was 6.35 million, almost exactly evenly divided between the developed and developing countries. In males, the most important sites were lung, stomach, colon/rectum, mouth/pharynx, prostate and oesophagus, and in females breast, cervix, colon/rectum, stomach, corpus uteri and lung. When the two sexes are combined, stomach cancer emerges as the most common cancer in 1980 (669,400 new cases per year), but this estimate is only slightly greater than that of lung cancer (660,500 new cases), and comparisons with earlier estimates for 1975 suggest that, with declining incidence rates for stomach cancer and the continuing rise for lung cancer, the latter would become the most common cancer in the world by the end of 1981. The implications for cancer control in the developed and developing countries of the world are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3338870     DOI: 10.1002/ijc.2910410205

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  177 in total

1.  Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples.

Authors:  K W Hart; O M Williams; N Thelwell; A N Fiander; T Brown; L K Borysiewicz; C M Gelder
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 2.  The risk of large bowel cancer after partial gastrectomy for benign ulcer disease.

Authors:  G Lundegårdh; H O Adami; C Helmick; M Zack
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

Review 3.  Epidemiological research in stomach cancer: progress over the last ten years.

Authors:  H Boeing
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Functional properties of synthetic N-acyl-L-homoserine lactone analogs of quorum-sensing gram-negative bacteria on the growth of human oral squamous carcinoma cells.

Authors:  Hongbo Chai; Masaharu Hazawa; Naoko Shirai; Jun Igarashi; Kenji Takahashi; Yoichiro Hosokawa; Hiroaki Suga; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2010-09-28       Impact factor: 3.850

5.  Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain.

Authors:  N Aragonés; M Pollán; G López-Abente; M Ruiz; A Vergara; C Moreno; P Moreo; E Ardanaz
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

6.  Genetic heterogeneity of hepatocellular carcinoma.

Authors:  H Unsal; C Yakicier; C Marçais; M Kew; M Volkmann; H Zentgraf; K J Isselbacher; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  p53 mutations in gastric and colorectal cancers in Texas Hispanics versus Anglos.

Authors:  B G Schneider; S G Hilsenbeck; C H Hensel; V Pekkel; C H Shelton; H A Rodríguez-Martínez; M E Gutiérrez-Díaz; D R Pulitzer; D C Allred
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus.

Authors:  K Y Lam; S L Loke; X C Shen; L T Ma
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells.

Authors:  C D Woodworth; E McMullin; M Iglesias; G D Plowman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.